Actieve functies van Murty Bosukonda
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Thrasos, Inc.
 Thrasos, Inc. Pharmaceuticals: MajorHealth Technology Thrasos, Inc. discovers and develops drugs. The company develops protein mimetic compounds for Kidney and Heart disease. Thrasos is headquartered in Hopkinton, MA | Directeur/Bestuurslid | - | - |
Loopbaan van Murty Bosukonda
Eerdere bekende functies van Murty Bosukonda
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Oprichter | 01-01-2003 | - |
Statistieken
Internationaal
| Verenigde Staten | 2 |
| Canada | 2 |
Operationeel
| Director/Board Member | 1 |
| Founder | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Thrasos, Inc.
Thrasos, Inc. Pharmaceuticals: MajorHealth Technology Thrasos, Inc. discovers and develops drugs. The company develops protein mimetic compounds for Kidney and Heart disease. Thrasos is headquartered in Hopkinton, MA | Health Technology |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
- Beurs
- Insiders
- Murty Bosukonda
- Ervaring
